Table 2.
Number | Gender | Age | Treatment | Diagnosis of infection | Bacterial etiology | Days of infection detected after TACE and/or RFA | PCT on day of fever | Peak PCT within 7 days | Outcome of infection |
---|---|---|---|---|---|---|---|---|---|
1 | M | 57 | TACE | Cholecystitis | Bile, E. hirae | 4 | 2.58 | 2.58 | Cured |
2 | M | 83 | TACE | Pneumonia | — | 5 | 0.72 | 0.72 | Cured |
3 | M | 55 | TACE | UTI | — | 4 | 0.23 | 2.40 | Cured |
4 | M | 75 | TACE | Bacteremia, primary | Blood, E. coli | 2 | 1.55 | 1.70 | Cured |
5 | M | 79 | TACE | UTI | — | 3 | 1.19 | 1.19 | Cured |
6 | M | 73 | TACE | Pneumonia | Sputum, E. coli | 7 | 0.21 | 0.24 | Cured |
7 | F | 77 | Sequential TACE/RFA | Liver abscess | Blood, E. casseliflavus | 7 | 0.16 | 0.59 | Transferred to another hospital |
8 | M | 71 | TACE | Bacteremia, cholangitis | Blood, E. gallinarum | 1 | 0.15 | 0.55 | Cured |
9 | F | 65 | RFA | Bacteremia, RFA site cutaneous abscess | Blood, S. aureus | 1 | 0.08 | 0.17 | Cured |
TACE: transarterial chemoembolization; RFA: radiofrequency ablation; UTI: urinary tract infection; PCT: procalcitonin.